Special Containment Procedures
RSCP-040 instances must be kept in a quarantined and locked down spherical plastic shell with adjustable outer radius and inner radius. Currently, the outer radius has been set to 12 feet and the inner radius has been set to six feet. If RSCP-040 instances replicate, the inner radius must be increased as well as the outer radius. If RSCP-040 instances are neutralized, the outer radius and the inner radius will have to be decreased as well. Robloxians entering the sphere-shaped plastic shell must wear facial protection and/or be vaccinated against RSCP-040.
Description
RSCP-040 is a contagious and self-replication viral infection that causes inflammation of the bronchial tubes of the Robloxians, which are the airways that carry air into the Robloxian lungs. When the tubes are infected, they swell. Mucus or thick fluid forms inside the infected tubes. This narrows the airways, making it harder for Robloxians to breathe. RSCP-040 then attacks the lungs, nose, and throat. Young, older, and pregnant Robloxians, as well as Robloxians with chronic disease or weak immune systems are at high risk.
As a consequence, the Robloxian suffers from fever, chills, muscle aches, cough, congestion, runny nose, headaches, and fatigue.
RSCP-040 can be partly treated with rest and fluid to let the Robloxian fight the infection on its own. Over-the-counter anti-inflammatory pain relievers may help with symptoms. An annual vaccine can partly help prevent RSCP-040 and limit RSCP-040's complications.
0.01% of Robloxians are infected annually with RSCP-040. While RSCP-040 can disperse in many ways (airborne respiratory droplets, saliva, skin-to-skin contact, and exposure to contaminated surfaces), RSCP-040 is usually self-treatable and self-diagnosable. The symptoms of RSCP-040 disappear in days to weeks. Few Robloxians require lab testing and imaging for RSCP-040.
RSCP-040 has been explained to be a mixture of acute bronchitis and influenza. RSCP-040 was first reported to be seen in a Robloxian in 3:47:53 PM, August 20, 2021.